Chiara de Waure
Real world evidence for public health decision-making on vaccination policies: perspectives from an expert roundtable
de Waure, Chiara; Gärtner, Barbara C.; Lopalco, Pier Luigi; Puig-Barbera, Joan; Nguyen-Van-Tam, Jonathan S.
Authors
Barbara C. Gärtner
Pier Luigi Lopalco
Joan Puig-Barbera
Jonathan S. Nguyen-Van-Tam
Abstract
INTRODUCTION: Influenza causes significant morbidity and mortality, but influenza vaccine uptake remains below most countries' targets. Vaccine policy recommendations vary, as do procedures for reviewing and appraising the evidence. AREAS COVERED: During a series of roundtable discussions, we reviewed procedures and methodologies used by health ministries in four European countries to inform vaccine recommendations. We review the type of evidence currently recommended by each health ministry and the range of approaches toward considering randomized controlled trials (RCTs) and real-world evidence (RWE) studies when setting influenza vaccine recommendations. EXPERT OPINION: Influenza vaccine recommendations should be based on data from both RCTs and RWE studies of efficacy, effectiveness, and safety. Such data should be considered alongside health-economic, cost-effectiveness, and budgetary factors. Although RCT data are more robust and less prone to bias, well-designed RWE studies permit timely evaluation of vaccine benefits, effectiveness comparisons over multiple seasons in large populations, and detection of rare adverse events, under real-world conditions. Given the variability of vaccine effectiveness due to influenza virus mutations and increasing diversification of influenza vaccines, we argue that consideration of both RWE and RCT evidence is the best approach to more nuanced and timely updates of influenza vaccine recommendations.
Citation
de Waure, C., Gärtner, B. C., Lopalco, P. L., Puig-Barbera, J., & Nguyen-Van-Tam, J. S. (2024). Real world evidence for public health decision-making on vaccination policies: perspectives from an expert roundtable. Expert Review of Vaccines, 23(1), 27-38. https://doi.org/10.1080/14760584.2023.2290194
Journal Article Type | Article |
---|---|
Acceptance Date | Nov 28, 2023 |
Online Publication Date | Dec 12, 2023 |
Publication Date | Jan 1, 2024 |
Deposit Date | Dec 21, 2023 |
Publicly Available Date | Dec 21, 2023 |
Journal | Expert Review of Vaccines |
Print ISSN | 1476-0584 |
Electronic ISSN | 1744-8395 |
Publisher | Taylor and Francis |
Peer Reviewed | Peer Reviewed |
Volume | 23 |
Issue | 1 |
Pages | 27-38 |
DOI | https://doi.org/10.1080/14760584.2023.2290194 |
Keywords | Influenza; influenza vaccination; vaccine effectiveness; vaccination recommendations; evidence base; evaluation methodology; public health |
Public URL | https://nottingham-repository.worktribe.com/output/28713799 |
Publisher URL | https://www.tandfonline.com/doi/full/10.1080/14760584.2023.2290194 |
Additional Information | Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.; Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ierv20; Received: 2023-11-04; Accepted: 2023-11-28; Published: 2023-12-12 |
Files
de Waure Expert Review od Vaccines 2024
(1.4 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc/4.0/
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search